# Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer

> **NCT00154778** · PHASE2 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 55 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Taxol, UFT,Leucovorin

## Key facts

- **NCT ID:** NCT00154778
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2007-07-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154778, "Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00154778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*